NCT05708235 2026-03-05
MiRaDoR
MedSIR
Phase 2 Recruiting
Clinical Trials
4 trialsNCT05896566 2026-02-24
PREcoopERA
ETOP IBCSG Partners Foundation
Phase 2 Completed
NCT04576455 2026-01-16
A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer)
Hoffmann-La Roche
Phase 2 Active not recruiting
NCT06259929 2025-02-18
Neo-AGILE
Fondazione Oncotech
Phase 2 Recruiting